Risk factors analysis of peripherally inserted central catheter associated thrombosis in lung cancer patients with chemotherapy
YUAN Na1 WANG Lei2 WU Xueliang3
1.Department of Radiotherapy, First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China;
2.Department of Intensive Care Unit, First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China;
3.Vascular Gland Surgery, First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China
Abstract：Objective To discuss the incidence rate and risk factors of peripherally inserted central catheter (PICC) related thrombosis in patients with lung cancer receiving chemotherapy. Methods From January 2014 to January 2015, in First Affiliated Hospital of Hebei North University, 157 patients with lung cancer receiving chemotherapy and PICC were selected and observed for 180 days. The diagnosis of thrombosis was based on Doppler Sonography. Age, gender, tumor type, clinical stage, treatment,c omplications, PICC catheter selection of vein, PICC catheter time, different chemotherapy drugs and the influence of PICC related thrombosis were analyzed by single factor and the multiple Logistic regression to study. Results Among 157 caces, 17 cases (10.8%) ocurred symptomatic PICC-related thrombosis. The patients were individed into PICC-related thrombosis group and no-PICC-related thrombosis group according into thrombosis occurrence. PICC-related thrombosis group and no-PICC-related thrombosis group were compared, the differences of gender, clinical stage, using Etoposide were statistically significant (P < 0.05), the differences of the age, tumor type, treatment, complication, PICC catheter selection of vein and PICC catheter time were not statistically significant (P > 0.05). the multiple Logistic regression analysis suggested that the risk of PICC related thrombosis with patients with lung cancer receiving of etoposide treatment increased 1.373 times, the risk of PICC related thrombosis in female was 1.219 times that in male,and the risk of ⅢB-Ⅳ stages was 4.347 times that ofⅡ-ⅢA stages. Conclusion The gender, clinical stages and using Etoposide are the risk factors in lung patients with PICC-related thrombosis.
[1] Chopra V，Anand S，Hickner A，et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and metaanalysis [J]. Lancet，2013，382（9889）：311-325.
[2] Tafur AJ，Kalsi H，Wysokinski WE，et al. The association of active cancer with venous thromboembolism location：a populationbased study [J]. Mayo Clin Proc，2011，86（1）：25-30.
[3] Connolly GC，Menapace L，Safadjou S， et al. Prevalence and clinical significance of incidental and clinically suspected venous thromboe -mbolism in lung cancer patients [J]. Clin Lung Cancer，2013，14（6）：713-718.
[4] Lee AY，Kamphuisen PW. Epidemiology and prevention of catheter-related thrombosis in patients with cancer [J]. J Thromb Haemost，2012，10（8）：1491-149.
[5] Luo L，Jing XM，Wang GR，et al. Peripherally inserted central catheter-related upper extremity venous thrombosis in oncology patients：a prospective study based on doppler sonography [J]. J Ultrasound Med， 2016，35（8）：1759-1763.
[6] Folsom AR，Alonso A，George KM，et al. Prospective study of plasma D-dimer and incident venous thromboembolism：the atherosclerosis risk in communities （ARIC） Study [J]. Thrombres，2015，136（4）：781-785．
[7] Chopra V，Ratz D，Kuhn L，et al. Peripherally inserted central catheter-related deep vein thrombosis：contemporary patterns and predictors [J]. J Thromb Haemost，2014，12（6）：847-854.
[8] Rosen T， Chang B， Kaufman M，et al. Emergency department diagnosis of upper extremity deep venous thrombosis using bedside ultrasonography [J]. Crit Ultrasound J，2012， 4（1）：1-4．
[9] Kang JR，Long LH，Yan SW， et al. Peripherally inserted central catheter -related vein thrombosis in patients with lung cancer [J]. Clin Appl Thromb Hemost，2017，23（2）：181-186.
[10] Corrales-Rodriguez L，Blais N. Lung cancer associated venous thromboembolic disease： a comprehensive review [J]. Lung Cancer，2012： 75（1）：1-8.
[11] Arslan S，Manduz S，Epoozturk K，et al. Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases [J]. Mol Biol Rep，2011，38（4）：2395-2400.
[12] 陈林，余春华，李俊英，等.肺癌患者PICC相关静脉血栓的回顾性分析[J].中国肺癌杂志，2015，9（18）：549-553.
[13] Bertoglio S，Faccini B，Lalli L，et al.Peripherally inserted central catheters in cancer patients under chemotherapy：a prospective study on the incidence of complications and overall failures [J]. J Surg Oncol，2016，113（6）：708-714.
[14] Fletcher JJ，Stetler W，Wilson TJ. The clinical significance of peripherally inserted central venous catheter-related deep vein thrombosis [J]. Neurocrit Care，2011， 15（3）：454-460.
[15] Cotogni P，Barbero C，Garrino C，et al. Peripherally inserted central catheters in non-hosiptalized cancer patients：5-year results of a prospective study [J]. Support Care Cancer，2015，23（2）：403-409.
[16] Zhang X，Huang JJ，Xia Y，et al. High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma [J]. Oncotarget，2016，7（23）：35404-35411.
[17] Liu Y， Gao Y， Wei L， et al. Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients：a double-center prospective investigation [J]. Ther Clin Risk Manag，2015，11（1）：153-160.
[18] 张玲芳，陶志芳，凡固华，等.经外周中心静脉置管化疗后置管侧上肢静脉血栓形成分析及对策[J].实用临床医药杂志，2016，22（20）：44-50.
[19] Ahn DH，lllum HB，Wang DH，et al. Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters：a retrospective analysis of risk factors [J]. J Oncol Pract，2013，9（1）：e8-e12.
[20] 张海燕，何文英.肿瘤外周中心静脉置管患者的健康教育模式研究进展[J].中国医学装备，2016，13（2）：141-144.
[21] 石果，罗凤，张玲.172例乳腺癌输液港静脉血栓相关因素分析[J].重庆医科大学学报，2016，5（41）：530-532.
[22] Moore RA，Adel N，Riedel E，et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy：a large retrospective analysis [J]. J Clin Oncol，2011：29（25）：3466-3473.
2017, Vol. 14 
京公网安备 11010502046598号